Location History:
- Newbury, GB (2012)
- Oxford, GB (2009 - 2022)
Company Filing History:
Years Active: 2009-2022
Title: The Innovative Contributions of Richard Harrop
Introduction
Richard Harrop, a prominent inventor based in Oxford, GB, has contributed significantly to the field of immunotherapy through his innovative patent developments. With a total of six patents to his name, Harrop focuses on novel approaches to treating haematological cancers.
Latest Patents
Among his latest patents is the invention related to 5T4-targeting agents and methods. This invention is centered on immunotherapeutic approaches aimed at treating haematological cancers. Specifically, it involves a method for targeting the 5T4 antigen, allowing for effective treatment by administering a 5T4-targeting agent to a subject. Additionally, his immunotherapeutic method patent outlines a way to monitor the efficacy of immunotherapy in mammals. This method utilizes a viral vector that transduces cells to express an antigen, providing insights into treatment effectiveness.
Career Highlights
Throughout his career, Richard Harrop has worked with notable companies in the biotech sector, including Oxford Biomedica Limited and Oxford Biomedica, Inc. His time at these organizations has enabled him to push the boundaries of cancer treatment through targeted therapies and innovative research.
Collaborations
Collaboration has been key in Harrop's innovation journey. He has worked alongside esteemed colleagues such as Miles William Carroll and William Shingler, contributing to the development of groundbreaking therapeutic solutions in the field of medicine.
Conclusion
Richard Harrop's commitment to advancing immunotherapeutic methods demonstrates his role as a crucial inventor in the fight against haematological cancers. With his continued innovation and collaboration, the future of cancer treatment looks promising.